title: Immunisation against the amino-terminal peptide (alpha N) of the alpha 43 subunit of inhibin impairs fertility in sheep.
abstract: Processing of the 58 kDa to the 31 kDa form of inhibin (Inh) involves cleavage of the amino-terminal peptide (alpha N) from the alpha 43-subunit. We show that active immunisation of female sheep against a recombinant bovine alpha N impairs their fertility. In Exp 1, 5 treated (Group 1; 300 micrograms alpha N) and 6 control ewes (Group 2; adjuvant only) were immunized (Day 1) and given boosters on Days 22 and 56. In Group 1, mean +/- SEM binding of 125I-31 kDa Inh was less than 0.5% on Days 33 and 44, whereas binding of 125I-58 kDa Inh was 4.9 +/- 0.7 and 6.2 +/- 0.6%, respectively. In Group 2 binding of both tracers was less than 0.5%. The corpora lutea (CL)/ewe in Group 1 on Days 44 and 82 were 1.8 +/- 0.2 and 2.8 +/- 0.9, respectively, and were not different from those in Group 2 (1.7 +/- 0.3 and 1.5 +/- 0.2, respectively). One ewe in Group 1 versus 5/6 ewes in Group 2 were diagnosed pregnant. In Exp 2, 18 treated and 16 controls were immunized as in Exp 1. The binding of 125I-58 kDa Inh in treated ewes (2.4 +/- 0.3%) was greater than in controls (less than 0.5%) on Day 56. The CL/ewe in treated ewes (1.8 +/- 0.2) was similar to that in controls (2.0 +/- 0.1) on Day 76. All 16 control ewes but only 7/17 treated ewes were subsequently diagnosed pregnant. The plasma progesterone concentrations were similar in treated ewes which did (7.6 +/- 1.2 nmol/L) and did not (7.0 +/- 0.7) become pregnant. Neither basal nor GnRH-stimulated concentrations of LH, nor basal concentrations of Inh differed between treated and controls in Exp 2. Similarly, there were no differences in FSH, except that basal concentrations were higher in the luteal phase of treated ewes. We conclude that immunisation of ewes against alpha N results in a significant reduction in fertility.
authors.affiliation: Medical Research Centre, Prince Henry's Campus, Monash Medical Centre, Melbourne Victoria, Australia.
authors.forename: J K
authors.initials: JK
authors.lastname: Findlay
authors.forename: C G
authors.initials: CG
authors.lastname: Tsonis
authors.forename: B
authors.initials: B
authors.lastname: Doughton
authors.forename: R W
authors.initials: RW
authors.lastname: Brown
authors.forename: K C
authors.initials: KC
authors.lastname: Bertram
authors.forename: G H
authors.initials: GH
authors.lastname: Braid
authors.forename: G C
authors.initials: GC
authors.lastname: Hudson
authors.forename: M L
authors.initials: ML
authors.lastname: Tierney
authors.forename: N H
authors.initials: NH
authors.lastname: Goss
authors.forename: R G
authors.initials: RG
authors.lastname: Forage
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000502:physiology; D005260:Female; D005298:Fertility; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007114:Immunization; D007265:Inhibins / Q000276:immunology / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D046911:Macromolecular Substances; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011994:Recombinant Proteins / Q000276:immunology; D012756:Sheep
chemical_list: D046911:Macromolecular Substances; D011994:Recombinant Proteins; D007987:Gonadotropin-Releasing Hormone; D007265:Inhibins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone